-
341
Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis
Published 2013-01-01“…Matrix metalloproteinase-3 (MMP-3) is involved in the immunopathogenesis of rheumatoid arthritis (RA), but little is known about its relationship to genetic susceptibility and biomarkers of disease activity, especially acute phase reactants in early RA. …”
Get full text
Article -
342
Biologic Cost per Effectively Treated Rheumatoid Arthritis Patient in a Large Managed Care Population: A Retrospective Cohort Study
Published 2015-09-01“…**Background:** Until recently, the lack of clinical outcomes information for rheumatoid arthritis (RA) in administrative claims databases limited their use in comparative effectiveness research. …”
Get full text
Article -
343
Impact of Likelihood Ratios of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody in Clinical Diagnosis of Rheumatoid Arthritis by Two Available Platforms
Published 2025-01-01Subjects: “…rheumatoid arthritis…”
Get full text
Article -
344
IgA vasculitis post-ChAdOx1 nCoV-19 vaccine in a patient with rheumatoid arthritis
Published 2022-01-01Subjects: “…rheumatoid arthritis…”
Get full text
Article -
345
Increased Serum Interleukin-2 Levels Are Associated with Abnormal Peripheral Blood Natural Killer Cell Levels in Patients with Active Rheumatoid Arthritis
Published 2020-01-01“…To investigate the relationship between serum interleukin-2 (IL-2) levels and disease activity, absolute numbers of peripheral lymphocyte subsets, autoantibodies, and associated cytokines in patients with rheumatoid arthritis (RA). Methods. This study included 106 patients with RA, evaluated their disease activity (DAS28 score), and divided them into disease remission (DAS28≤2.6), low disease activity (DAS28≤3.2), and moderate-high disease activity (DAS28>3.2) groups. …”
Get full text
Article -
346
-
347
Evaluation of Real-World Evidence to Assess Effectiveness Outcomes of Janus Kinase Inhibitors for Rheumatoid Arthritis: A Systematic Review of US Studies
Published 2025-01-01Subjects: “…rheumatoid arthritis…”
Get full text
Article -
348
Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects
Published 2021-06-01“…Early diagnosis and treatment of rheumatoid arthritis (RA) are of critical importance to halt the progression of the disease. …”
Get full text
Article -
349
-
350
-
351
MAPK4 inhibits the early aberrant activation of B cells in rheumatoid arthritis by promoting the IRF4-SHIP1 signaling pathway
Published 2025-01-01“…Abstract The involvement of B lymphocytes in the pathogenesis of rheumatoid arthritis (RA) is well-established, with their early and aberrant activation being a crucial factor. …”
Get full text
Article -
352
Deciphering hub genes and immune landscapes related to neutrophil extracellular traps in rheumatoid arthritis: insights from integrated bioinformatics analyses and experiments
Published 2025-01-01Subjects: “…rheumatoid arthritis…”
Get full text
Article -
353
-
354
Candidate antirheumatic genotherapeutic plasmid constructions have low immunogenicity
Published 2017-05-01Subjects: “…rheumatoid arthritis…”
Get full text
Article -
355
Genetic causality between insomnia and specific orthopedic conditions: Insights from a two-sample Mendelian randomization study
Published 2025-02-01Subjects: “…Insomnia, rheumatoid arthritis…”
Get full text
Article -
356
Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
Published 2025-01-01Subjects: “…Rheumatoid arthritis…”
Get full text
Article -
357
-
358
Predicting abatacept retention using machine learning
Published 2025-02-01Subjects: Get full text
Article -
359
Bifidobacterium animalis BD400 protects from collagen-induced arthritis through histidine metabolism
Published 2025-01-01Subjects: “…rheumatoid arthritis…”
Get full text
Article -
360